Phase 2 clinical trial, CANYON, shows potential at reducing muscle damage in Becker muscular dystrophy December 18, 2024 By charlotte roy
Project secures funding to continue genotype phenotype correlation of the DMD and BMD brain September 18, 2024 By amber sunner
Opportunity for people with Becker muscular dystrophy to take part in a Phase 2 clinical trial June 21, 2023 By